Cargando…

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials

The world is currently facing a novel COVID-19 pandemic caused by SARS-CoV-2 that, as of July 12, 2020, has caused a reported 12,322,395 cases and 556,335 deaths. To date, only two treatments, remdesivir and dexamethasone, have demonstrated clinical efficacy through randomized controlled trials (RCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapepula, Paulin M., Kabengele, Jimmy K., Kingombe, Micheline, Van Bambeke, Françoise, Tulkens, Paul M., Sadiki Kishabongo, Antoine, Decloedt, Eric, Zumla, Adam, Tiberi, Simon, Suleman, Fatima, Tshilolo, Léon, Muyembe-TamFum, Jean-Jacques, Zumla, Alimuddin, Nachega, Jean B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470522/
https://www.ncbi.nlm.nih.gov/pubmed/32705976
http://dx.doi.org/10.4269/ajtmh.20-0820